Sanara MedTech Inc.
SMTI
$34.73
$0.010.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.96% | 17.38% | 18.97% | 30.52% | 34.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.96% | 17.38% | 18.97% | 30.52% | 34.26% |
| Cost of Revenue | -4.49% | -5.88% | -7.60% | 2.82% | 7.73% |
| Gross Profit | 14.53% | 19.63% | 21.73% | 33.54% | 37.29% |
| SG&A Expenses | 10.51% | 7.58% | 8.14% | 14.45% | 16.89% |
| Depreciation & Amortization | 9.76% | -4.72% | -13.94% | -45.57% | -47.38% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.18% | 7.12% | 7.25% | 10.60% | 12.00% |
| Operating Income | 49.59% | 644.67% | 1,062.49% | 252.94% | 182.98% |
| Income Before Tax | -145.15% | 118.41% | 91.41% | 128.57% | 109.48% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -145.15% | 118.41% | 91.41% | 128.57% | 109.48% |
| Earnings from Discontinued Operations | -199.97% | -324.45% | -621.52% | -1,361.19% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -72.88% | -79.34% | -91.26% | -94.03% | -95.08% |
| Net Income | -222.15% | -193.82% | -288.66% | -348.29% | -51.36% |
| EBIT | 49.59% | 644.67% | 1,062.49% | 252.94% | 182.98% |
| EBITDA | 34.30% | 197.61% | 365.18% | 855.84% | 340.55% |
| EPS Basic | -219.19% | -189.91% | -282.11% | -339.97% | -49.09% |
| Normalized Basic EPS | 36.21% | 184.95% | 135.11% | 126.72% | 111.87% |
| EPS Diluted | -210.73% | -181.85% | -272.10% | -328.42% | -48.86% |
| Normalized Diluted EPS | 34.84% | 182.96% | 134.01% | 126.16% | 111.68% |
| Average Basic Shares Outstanding | 0.75% | 1.03% | 1.08% | 1.70% | 1.87% |
| Average Diluted Shares Outstanding | 1.49% | 3.63% | 2.87% | 3.50% | 2.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |